Sravan Kumar Emany Ironwood Pharmaceuticals Inc (IRWD) insider trading activity

Sravan Kumar Emany is SVP, COO and CFO of IRONWOOD PHARMACEUTICALS INC. Currently has a direct ownership of 309,572 shares of IRWD, which is worth approximately $1.2 Million. The most recent transaction as insider was on Nov 18, 2024, when has been sold 11,001 shares (Class A Common Stock) at a price of $4.08 per share, resulting in proceeds of $44,884. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 310K

3.43% 3M change

70.03% 12M change

Total Value Held $1.2 Million

Sravan Kumar Emany Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 18 2024	SELL Open market or private sale	$44,884 $4.08 p/Share	11,001 Reduced 3.43%	309,572 Class A Common Stock
May 16 2024	SELL Payment of exercise price or tax liability	$121,379 $6.64 p/Share	18,280 Reduced 5.39%	320,573 Class A Common Stock
Mar 08 2024	BUY Exercise of conversion of derivative security	-	37,120 Added 9.87%	338,853 Class A Common Stock
Mar 04 2024	BUY Open market or private purchase	$100,215 $9.38 p/Share	10,684 Added 3.42%	301,733 Class A Common Stock
Feb 12 2024	BUY Grant, award, or other acquisition	-	65,312 Added 18.33%	291,049 Class A Common Stock
Feb 08 2024	SELL Payment of exercise price or tax liability	$615,846 $14.9 p/Share	41,332 Reduced 15.48%	225,737 Class A Common Stock
Jan 17 2024	BUY Grant, award, or other acquisition	-	85,000 Added 24.14%	267,069 Class A Common Stock
Nov 16 2023	SELL Payment of exercise price or tax liability	$62,879 $9.44 p/Share	6,661 Reduced 3.53%	182,069 Class A Common Stock
Sep 15 2023	BUY Open market or private purchase	$300,119 $8.32 p/Share	36,072 Added 16.05%	188,730 Class A Common Stock
Mar 08 2023	BUY Grant, award, or other acquisition	-	74,236 Added 32.72%	152,658 Class A Common Stock
Nov 21 2022	SELL Open market or private sale	$76,041 $11.56 p/Share	6,578 Reduced 7.74%	78,422 Class A Common Stock
Dec 06 2021	BUY Grant, award, or other acquisition	-	85,000 Added 50.0%	85,000 Class A Common Stock

Also insider at

ASRT

Assertio Holdings, Inc. Healthcare

Director

SKE